Skip to main content
Home
Company
About Us
Executive Team
Board of Directors
Scientific & Clinical Advisors
Partners
Technology
Itolizumab
Multi-Cytokine Inhibitor Platform
Publications
Presentations
Clinical
Pipeline
Clinical Studies
Expanded Access Policy
Investors
Investor Overview
Stock Information
Stock Chart
Analyst Coverage
Press Releases
Events & Presentations
Email Alerts & Contacts
SEC Filings
Corporate Governance
Governance Documents
Committee Composition
Investor FAQs
Careers
Contact Us
Search query
Contact Us
Equillium, Inc. (Headquarters)
2223 Avenida De La Playa, Suite 105
La Jolla, California 92037
858-240-1200
Company Contacts
General Contact
info@equilliumbio.com
Investor Inquiries
ir@equilliumbio.com
Patient Advocacy Inquiries
advocacy@equilliumbio.com
Media Inquiries
media@equilliumbio.com
Medical Information
medinfo@equilliumbio.com
Career Inquiries
careers@equilliumbio.com
Clinical Trial Information
clinicaltrials@equilliumbio.com